Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.
Dengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify sm...
Main Authors: | Maywan Hariono, Sy Bing Choi, Ros Fatihah Roslim, Mohamed Sufian Nawi, Mei Lan Tan, Ezatul Ezleen Kamarulzaman, Nornisah Mohamed, Rohana Yusof, Shatrah Othman, Noorsaadah Abd Rahman, Rozana Othman, Habibah A Wahab |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0210869 |
Similar Items
-
Development of a NS2B/NS3 protease inhibition assay using AlphaScreen® beads for screening of anti-dengue activities
by: Muhammad Asyraf Abduraman, et al.
Published: (2018-12-01) -
Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1
by: Rothan Hussin A, et al.
Published: (2012-11-01) -
Protegrin-1 Inhibits Dengue NS2B-NS3 Serine Protease and Viral Replication in MK2 Cells
by: Hussin A. Rothan, et al.
Published: (2012-01-01) -
Polyprotein processing activity of DENV NS3 N369 mutants &Characterization of DENV NS protein interactions by BiFC
by: Yun-Ting Wang, et al.
Published: (2017) -
Constructing computational models of DENV NS2B/NS3 protease for drug repurposing
by: Li, Zhe-Xun, et al.
Published: (2016)